Pharma & Biotech

Investors in the telemedicine platform Hims & Hers are facing a complex investment landscape. While the company continues to demonstrate...

Biotechnology firm Inovio Pharmaceuticals has triggered investor alarm with a deeply discounted stock offering that aims to secure crucial funding....

The stock performance of artificial intelligence healthcare company Tempus AI has become a focal point for investor debate this year....

Biotechnology firm Altimmune is witnessing a substantial rally in its share price following the release of impressive mid-stage clinical trial...

Biopharmaceutical firm Ocugen presents investors with a classic dilemma: promising clinical developments in gene therapy set against a backdrop of...

Genetic testing specialist Natera has delivered a quarterly report that significantly surpassed market forecasts, propelling its stock upward. The company...

Pharmaceutical giant Eli Lilly has made a decisive move in its corporate benefits strategy, immediately dropping CVS Health as its...

Novo Nordisk's stock is showing signs of life after a prolonged downturn, but investors remain divided on whether this represents...

The independent journey of Allakos as a publicly traded biopharmaceutical firm has concluded following its acquisition by Concentra Biosciences. Shareholders...

Investors are rallying behind BioNTech stock despite the company's recent quarterly loss, signaling a potential turnaround for the vaccine developer....